Glycopyrronium, also known as NVA237 or glycopyrrolate, is a racemic mixture of two enantiomers. They are both quaternary ammonium compounds and long acting muscarinic antagonists. It is one of the most commonly prescribed anticholinergic medications. Early research into glycopyrronium use was for its indication as an adjunct therapy in the treatment of pept...
Glycopyrronium formulated as a topical cloth is indicated to treat primary axillary hyperhidrosis in patients ≥9 years, and an inhalational solution is indicated for long term maintenance of airflow obstruction in COPD. A glycopyrronium intravenous and intramuscular injection is indicated in adults and pediatric patients to reduce the volume and acidity of g...
WVU Medicine, Morgantown, West Virginia, United States
McGill University Health Center, Montreal, Quebec, Canada
MUHC, Montréal, Quebec, Canada
Mount Sinai Beth Israel, New York, New York, United States
Mount Sinai Queens, Long Island City, New York, United States
The Mount Sinai Hospital, New York, New York, United States
Dr. BishnuPokharel, Dharān Bāzār, Sunsari, Nepal
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
Cleveland Clinic, Cleveland, Ohio, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.